隆胸后乳腺癌:乳房切除患者的肿瘤学与重建考量
该回顾性研究分析了1993至2014年在该机构因乳腺癌接受乳房切除的有隆胸史女性(89例,95侧乳腺癌),并与2010年无隆胸史接受乳房切除的女性(171例,179侧乳腺癌)比较。结果显示两组在诊断分期和检测方法上无差异,但乳腺下植入隆胸者更易诊断为浸润性癌且更常通过自检发现。推荐对乳腺下隆胸女性加强乳腺癌筛查。
要点
- 有隆胸史与无隆胸史女性的乳腺癌诊断分期相似(p=0.19)。
- 乳腺下植入隆胸者更易诊断为浸润性癌而非导管原位癌(p=0.01)。
- 乳腺下植入隆胸者更常通过自检而非筛查钼靶发现肿瘤(p=0.03)。
核心结论
- 有隆胸史与无隆胸史女性的乳腺癌诊断分期相似。
- 在隆胸女性中,乳腺下植入与更晚期的肿瘤相关,且更常通过触诊而非钼靶发现。
- 推荐对乳腺下隆胸女性加强乳腺癌筛查警惕性。
研究设计与样本
- 回顾性分析1993至2014年在该机构因乳腺癌接受治疗性乳房切除的有隆胸史女性(89例,95侧乳腺癌)。
- 对照组为2010年无隆胸史接受乳房切除的所有女性(171例,179侧乳腺癌)。
- 根据既往植入物位置进行亚组分析:乳腺下(27侧)或胸肌下(63侧),5侧位置未知。
主要发现
- 有与无隆胸史女性的乳腺癌诊断分期无差异(p=0.19)。
- 有与无隆胸史女性的检测方法无差异(p=0.48)。
- 与胸肌下隆胸相比,乳腺下隆胸与诊断浸润性乳腺癌而非导管原位癌相关(p=0.01)。
- 与胸肌下隆胸相比,乳腺下隆胸与通过自检而非筛查钼靶检测相关(p=0.03)。
- 隆胸女性更倾向于选择即刻两阶段假体重建(p<0.01)。
临床怎么用
- 对乳腺下隆胸女性应加强乳腺癌筛查警惕性。
- 隆胸女性乳房切除后重建时,即刻两阶段假体重建是优先选择。
局限性
- 回顾性研究设计。
- 证据等级为治疗性III级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Breast augmentation with subglandular versus subpectoral implants may differentially impact the early detection of breast cancer and treatment recommendations. The authors assessed the impact of prior augmentation on the diagnosis and management of breast cancer in women undergoing mastectomy. METHODS: Breast cancer diagnosis and management were retrospectively analyzed in all women with prior augmentation undergoing therapeutic mastectomy at the authors' institution from 1993 to 2014. Comparison was made to all women with no prior augmentation undergoing mastectomy in 2010. Subanalyses were performed according to prior implant placement. RESULTS: A total of 260 women with (n = 89) and without (n = 171) prior augmentation underwent mastectomy for 95 and 179 breast cancers, respectively. Prior implant placement was subglandular (n = 27) or subpectoral (n = 63) (For five breasts, the placement was unknown). Breast cancer stage at diagnosis (p = 0.19) and detection method (p = 0.48) did not differ for women with and without prior augmentation. Compared to subpectoral augmentation, subglandular augmentation was associated with the diagnosis of invasive breast cancer rather than ductal carcinoma in situ (p = 0.01) and detection by self-palpation rather than screening mammography (p = 0.03). Immediate two-stage implant reconstruction was the preferred reconstructive method in women with augmentation (p < 0.01). CONCLUSIONS: Breast cancer stage at diagnosis was similar for women with and without prior augmentation. Among women with augmentation, however, subglandular implants were associated with more advanced breast tumors commonly detected on palpation rather than mammography. Increased vigilance in breast cancer screening is recommended among women with subglandular augmentation. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Cho EH, Shammas RL, Phillips BT, et al. Breast Cancer after Augmentation: Oncologic and Reconstructive Considerations among Women Undergoing Mastectomy. Plast Reconstr Surg. 2017. PMID: 28538550. doi:10.1097/PRS.0000000000003342
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。